UA111150C2 - Heterocyclic compound as an inhibitor of the cyclic subdivision of cell subdivision of cell 9, a medicament comprising, its administration, and a method of inhibition of the cytosine 7 and 7; - Google Patents
Heterocyclic compound as an inhibitor of the cyclic subdivision of cell subdivision of cell 9, a medicament comprising, its administration, and a method of inhibition of the cytosine 7 and 7;Info
- Publication number
- UA111150C2 UA111150C2 UAA201210796A UAA201210796A UA111150C2 UA 111150 C2 UA111150 C2 UA 111150C2 UA A201210796 A UAA201210796 A UA A201210796A UA A201210796 A UAA201210796 A UA A201210796A UA 111150 C2 UA111150 C2 UA 111150C2
- Authority
- UA
- Ukraine
- Prior art keywords
- subdivision
- cell
- cytosine
- medicament
- inhibition
- Prior art date
Links
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 title 2
- 125000004122 cyclic group Chemical group 0.000 title 1
- 229940104302 cytosine Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 230000005764 inhibitory process Effects 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Сполука винаходу є придатною для профілактики або лікування раку.Даний винахід стосується сполуки, представленої формулою (І):,де кожен символ формули є таким, як визначено в описі винаходу, або її солі або пролікарської форми, що є корисними для профілактики або лікування раку.The present invention relates to a compound represented by formula (I): wherein each symbol of the formula is as defined in the description of the invention, or salts or prodrugs thereof, useful for the prevention or treatment of cancer .
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010031899 | 2010-02-17 | ||
| PCT/JP2011/053303 WO2011102399A1 (en) | 2010-02-17 | 2011-02-16 | Heterocyclic compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA111150C2 true UA111150C2 (en) | 2016-04-11 |
Family
ID=55861965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201210796A UA111150C2 (en) | 2010-02-17 | 2011-02-16 | Heterocyclic compound as an inhibitor of the cyclic subdivision of cell subdivision of cell 9, a medicament comprising, its administration, and a method of inhibition of the cytosine 7 and 7; |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA111150C2 (en) |
-
2011
- 2011-02-16 UA UAA201210796A patent/UA111150C2/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2875877C (en) | Syk inhibitors | |
| BR112014008495A2 (en) | protein kinase inhibitors | |
| PH12017501326A1 (en) | Tgf-� inhibitors | |
| EA201290800A1 (en) | Heterocyclic Compound | |
| NZ715747A (en) | Syk inhibitors | |
| GEP201606532B (en) | Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1 | |
| PH12016500225B1 (en) | Novel quinoline-substituted compound | |
| MD4556C1 (en) | Compounds inhibiting the activity of catechol O-methyltransferase | |
| EA201490919A1 (en) | DERIVATIVES OF BETULINA | |
| EA201490724A1 (en) | SUBSTITUTED COMPOUNDS OF TETRAHYDROISOCHINOLINE AS INHIBITORS OF XIA | |
| MD4602B1 (en) | Inhibitors of hepatitis C virus | |
| EA201890254A2 (en) | GLUKOSILTSERAMIDSINTAZY INHIBITORS | |
| EA201200102A1 (en) | COMPOUNDS APPLICABLE AS A MEDICINE | |
| MD20140044A2 (en) | 2-Thiopyrimidinones and their use for the treatment of cardiovascular diseases | |
| IN2014DN07509A (en) | ||
| NZ595705A (en) | Protease inhibitors | |
| PH12015502429A1 (en) | Dicarboxylic acid compound | |
| MX2013008340A (en) | Novel 4-amino-n-hydroxy-benzamides as hdac inhibitors for the treatment of cancer. | |
| BR112013027395A2 (en) | 17alphahydroxylase / c17,20-lyase inhibitors | |
| MX2012013589A (en) | 2 -amino- pyrimidine derivatives useful as inhibitors of jnk. | |
| EA201200764A1 (en) | HINAZOLIN DERIVATIVES | |
| IN2014CN04922A (en) | ||
| UA111150C2 (en) | Heterocyclic compound as an inhibitor of the cyclic subdivision of cell subdivision of cell 9, a medicament comprising, its administration, and a method of inhibition of the cytosine 7 and 7; | |
| EA201300408A1 (en) | DERIVATIVES OF PHENYLKHINAZOLINE |